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Significance of this study
What is already known about this subject?
 ► As has been summarised in reviews and meta- 
analysis studies, there is an association between 
diabetes and inner ear dysfunction; the mechanisms 
lying beneath this association, however, are not 
known.
 ► We have previously shown that cells from the human 
inner ear sensory epithelium express the insulin re-
ceptor as well as insulin signaling components.
 ► Now we wonder: Does insulin direct action, or de-
fects in insulin- triggered signaling, contribute to 
hearing dysfunction in diabetes?
What are the new findings?
 ► Insulin impacts on inner ear functions by mecha-
nisms classically associated with insulin signaling 
in target cells.
 ► Inner ear insulin resistance might contribute to 
diabetes- associated inner ear dysfunction.
How might these results change the focus of 
research or clinical practice?
 ► Pure tone audiometry, auditory brain stem response 
and distortion products otoacustic emissions, con-
ventional testing methods for early diagnosis of 
hearing loss, could be used in the following up of 
patients with diabetes to prevent further disease 
progression of inner ear functions.
AbStrAct
Objective The mechanisms underlying the association 
between diabetes and inner ear dysfunction are not known 
yet. The aim of the present study is to evaluate the impact 
of obesity/insulin resistance on inner ear fluid homeostasis 
in vivo, and to investigate whether the organ of Corti could 
be a target tissue for insulin signaling using auditory House 
Ear Institute- Organ of Corti 1 (HEI- OC1) cells as an in vitro 
model.
Methods High fat diet (HFD) fed C57BL/6J mice were 
used as a model to study the impact of insulin resistance 
on the inner ear. In one study, 12 C57BL/6J mice were 
fed either control diet or HFD and the size of the inner ear 
endolymphatic fluid compartment (EFC) was measured 
after 30 days using MRI and gadolinium contrast as a 
read- out. In another study, the size of the inner ear EFC 
was evaluated in eight C57BL/6J mice both before and 
after HFD feeding, with the same techniques. HEI- OC1 
auditory cells were used as a model to investigate insulin 
signaling in organ of Corti cells.
Results HFD feeding induced an expansion of the EFC 
in C57BL/6J mice, a hallmark of inner ear dysfunction. 
Insulin also induced phosphorylation of protein kinase B 
(PKB/Akt) at Ser473, in a PI3- kinase- dependent manner. 
The phosphorylation of PKB was inhibited by isoproterenol 
and IBMX, a general phosphodiesterase (PDE) inhibitor. 
PDE1B, PDE4D and the insulin- sensitive PDE3B were 
found expressed and catalytically active in HEI- OC1 
cells. Insulin decreased and AICAR, an activator of AMP- 
activated protein kinase, increased the phosphorylation 
at the inhibitory Ser79 of acetyl- CoA carboxylase, the 
rate- limiting enzyme in de novo lipogenesis. Furthermore, 
the activity of hormone- sensitive lipase, the rate- limiting 
enzyme in lipolysis, was detected in HEI- OC1 cells.
Conclusions The organ of Corti could be a target tissue 
for insulin action, and inner ear insulin resistance might 
contribute to the association between diabetes and inner 
ear dysfunction.
InTROduCTIOn
Ample evidence shows that type 1 and type 
2 diabetes negatively impact on the function 
of the vestibular and auditory systems both in 
humans and in animal models.1–5 Although 
several theories have been proposed (eg, 
microangiopathy, advanced glycation end 
products, reactive oxidative stress and mito-
chondrial dysfunction, demyelination of the 
auditory nerve, spiral ganglion loss and atro-
phic changes of organ of Corti cells5–9), the 
exact underlying mechanisms responsible 
for diabetes- induced damage to the auditory 
system remain uncertain.
The progression of hearing loss in mice 
with type 1 diabetes induced with streptozo-
tocin or type 2 diabetes induced with high fat 
die (HFD), respectively, has been reported to 
have different characteristics as measured by 
auditory brain stem response and distortion 
products otoacustic emissions (DPOAE).10 
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Furthermore, hyperinsulinemia, a marker for insulin 
resistance and type 2 diabetes, has been suggested to 
explain differences in dysfunction of specific auditory 
pathways in the two types of diabetes in a comprehensive 
neuro- electrophysiological study in mice.11 In humans, 
insulin resistance, impaired fasting glucose and beta- 
cell dysfunction have been reported as independent 
risk factors for hearing impairment even before the 
onset of type 2 diabetes.12 Thus, a number of studies are 
in agreement with reports showing harmful effects of 
induced hyperinsulinemia on inner ear metabolic and 
ion homeostasis.13–16
The role of the cochlea as a direct target organ for 
insulin action has not been well characterized. Recently, 
it was reported that the insulin receptor is expressed 
specifically in supporting cells of the organ of Corti17 
in agreement with early studies showing high affinity 
binding sites for insulin in the cochlea.18 Also, previous 
results from our laboratory demonstrated the expres-
sion of the insulin receptor, insulin receptor substrate 1, 
protein kinase B (PKB/Akt), the insulin- sensitive phos-
phodiesterase (PDE) 3B as well as targets such as the 
insulin- regulated glucose transporter 4, in the sensory 
epithelium of the human saccule.19 20
The C57BL/6 mouse strain fed HFD is a commonly 
used animal model for studies of the pathophysiology 
of insulin resistance, impaired glucose homeostasis and 
early type 2 diabetes.21 In the present study, we investi-
gated the impact of insulin resistance on the size of the 
cochlear endolymphatic fluid compartment (EFC) in 
vivo in HFD- fed C57BL/6J mice using MRI with contrast. 
Endolymphatic hydrops (EH), an expansion of the EFC, 
was looked on as a marker for risk to develop cochlear 
dysfunction. We have previously used MRI and gado-
linium contrast to demonstrate that EH develops in 
response to treatment with vasopressin and family selec-
tive PDE inhibitors, cilostamide, rolipram and sildenafil, 
respectively20 22 and furthermore shown that hydrops can 
be prevented by spironolactone administration under 
specific conditions.23
To study insulin signaling in vitro, House Ear Institute- 
Organ of Corti 1 (HEI- OC1) auditory cells, one of the 
few auditory cell lines available for research purposes, 
were used.24 HEI- OC1 cells are considered a model for 
organ of Corti cells since they express markers for both 
hair cells and supporting cells.
MeTHOds
Animals and high fat diet interventions
A total of 20 female, 8 weeks of age, C57BL/6J mice 
(Taconic, Denmark) were on a 12 hours light cycle with 
non- restricted food and water intake.
Study 1: six C57BL/6J mice were fed HFD (D12492, 
60 E% fat content; Research Diets, New Brunswick, New 
Jersey, USA) and six mice were fed control diet (CD) for 
30 days. Thereafter, the areas of the EFCs were evaluated 
using MRI with gadolinium contrast as described in 
Magnetic resonance imaging.
Study 2: eight C57BL/6J mice were fed HFD for 30 
days. The areas of the EFC were evaluated twice for each 
mouse, both before and after 30 days of HFD, using MRI 
with gadolinium contrast.
Magnetic resonance imaging
Animals were anesthetized with 3.5% isoflurane in a 
mixture with 200 mL/min oxygen and 200 mL/min 
nitrous oxide and maintained at 1.5%–2% isoflurane 
inside the magnet. Gadolinium contrast agent (Dotarem, 
Guerbet, Villepinte, France) (gadoteric acid, 279.3 mg/
mL, 0.5 mmol/mL) was administered intraperitoneally 
(100 μg/20 g) in the left abdominal quadrant 55–65 min 
before MRI. The induction chamber was kept warm at 
37°C. Inside the magnet, the respiratory rate of the animal 
was monitored (SA Instruments, New York, USA) and the 
body temperature was maintained using a Lauda Rc6 CS 
recirculating water bath (Köningshofen, Germany).
MRI was performed as previously described20 22 23 with 
a 9.4 T magnet (Agilent, Palo Alto, USA) using Avance 
III electronics (Bruker, Ettlingen, Germany). The system 
is equipped with a 12 cm inner diameter gradient system 
having a maximum gradient strength of 670 mT/m. The 
animals were imaged using a quadrature transmit/receive 
cryoprobe (Bruker). T1- weighted three- dimensional 
(3D) images were acquired with a gradient echo 3D 
sequence; repetition time TR: 11 ms, echo time TE: 3.695 
ms, number of averages: 2, data matrix size 220×220×147 
pixels, field of view 15×15×10 mm3. Images were recon-
structed by zero filling to increase the apparent resolu-
tion of the image to a matrix size of 440×440×294 pixels 
and an apparent pixel resolution of 0.034 mm.
Quantitative assessment of gadolinium in the endolymphatic 
relative to the perilymphatic space
Synedra view personal 16 (Synedra, Innsbruck, Austria), 
as well as Adobe Photoshop CS5 (Adobe, San Jose, USA), 
were used for postproduction processing of images, for 
the quantification of signal intensity in regions of interest 
and for labeling and demonstration of perilymph in the 
scala tympani (ST) and scala vestibule (SV) and endo-
lymph in the scala media (SM). Images parallel to the 
modiolus of mouse cochleae were used for measure-
ments.20 22 23 To evaluate the effect of various treatments 
on the size of the EFC, the relative area of SM in the basal 
turn of the cochlea was estimated by calculating the ratio 
between SM (endolymph, non- contrast enhanced) and 
SM plus SV (perilymph, contrast enhanced). The ratio of 
areas was subsequently converted to percentage as shown 
in figures 1 and 2. The observer assessing and outlining 
the perilymphatic and endolymphatic sizes, was blinded 
to the treatments given.
HeI-OC1 auditory cells and culture
HEI- OC1 cells were cultured in 6- well plates (6- well TC 
(tissue culture) plate standard, Sarstedt, Numbrecht, 
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Figure 1 High fat diet (HFD) feeding induces expansion of the endolymphatic fluid compartment in C57BL/6J mice as 
compared with mice fed control diet (CD). (A) Relative areas of endolymphatic compartments in individual ears. (B) Ears in 
the CD and HFD groups (mean±SEM: 65.3±2.5 and 70.4±3.4, respectively; p=0.00088). (C) Right and left ears in CD and 
HFD groups (mean±SEM: 64.7±3.7 and 70.7±4.3; p=0.028 for right ears and 66.0±1.1 and 70.0±3.1; p=0.011 for left ears). R, 
right; L, left. (D) Example of images parallel to the modiolus of cochlea of mice fed HFD or CD analyzed by MRI is shown. The 
gadolinium contrast moves into the perilymph (SV and ST), but not into the endolymph (SM), therefore the perilymph looks 
white and the endolymph looks black. Note the significant decrease in SV relative area after HFD feeding. The relative area 
of SM in the basal turn of the cochlea was estimated as described in ‘Methods’ section. The ratio of areas was subsequently 
converted to percentage as shown in A–C. SV, scala vestibule; ST, scala tympani; SM, scala media; 1st, first turn; 2nd, second 
turn. (E) Time course in changes in body weight from baseline at 8 weeks of age and during 30 days on CD (six mice) and HFD 
(six mice). MRI was performed at day indicated. Data are presented as means±SD. *P<0.05, **p<0.01,***p<0.001, HFD vs CD.
Germany) under permissive conditions (33°C, 10% CO2) 
in high- glucose Dulbecco’s Modified Eagle Medium 
(Sigma) containing 10% fetal bovine serum (Sigma) 
without antibiotics.24 After reaching 70%–80% conflu-
ence cells were washed twice with phosphate- buffered 
saline and preincubated for 2 hours in Krebs- Ringer bicar-
bonate buffer containing 2 mM glucose, 10 mM HEPES, 
pH 7.4, 120 mM NaCl, 5 mM NaHCO3, 5 mM KCl, 1.2 mM 
KH2PO4, 2.5 mM CaCl2, 1.2 mM MgSO4 and 0.2% bovine 
serum albumin (BSA). Thereafter, fresh buffer was 
added and cells were treated as indicated in the ‘Results’ 
section. After treatments, the cells were harvested in a 
buffer containing 50 mM TES (N-[Tris(hydroxymethyl)
methyl]-2- aminoethanesulfonic acid), pH 7.4, 250 mM 
sucrose, 1 mM EDTA, 2 mM ethylene glycol tetraacetic 
acid (EGTA), 40 mM phenyl- phosphate, 5 mM sodium 
fluoride, 1 mM dithiothreitol (DTT), 50 μM sodium 
vanadate, Pefabloc (Sigma), Complete (Roche, protease 
inhibitors) and 1% NP40 (200 μL/well) and subjected to 
sonication (10 short pulses). The lysates were centrifuged 
for 5 min at 5000×g, 4°C and the supernatants were used 
for further analysis.
sds-PAGe and western blot analysis
HEI- OC1 cell lysates (20–30 μg protein as measured 
by Bradford) were mixed with LDS (Lauryl Dodecyl 
Sulphate) sample buffer 4X (Invitrogen) containing 
300 mM DTT and subjected to electrophoresis on 
4%–12% bisacrylamide gels (Novex, Invitrogen). Proteins 
were transferred to Immobilon- P, PVDF (Polyvinylidene 
Fluoride) membranes (Merck Millipore), blocked with 
10% milk in Tris- buffered saline tween-20 (50 mM Tris, 
pH 7.6, 150 mM NaCl and 0.1% Tween-20) for 30 min 
and incubated at 4°C overnight with primary antibodies 
as indicated. Membranes were incubated with secondary 
antibody conjugated with horseradish peroxidase (HRP) 
for 1 hour at room temperature, incubated with Super-
Signal West Pico ECL (enzymatic chemiluminescence) 
reagent (Thermo Scientific, Rockford, USA) for 10 min 
followed by imaging (Molecular Imager ChemiDoc XRS+, 
Bio- Rad Laboratories, Solna, Sweden) and quantification 
(Image lab software, V.3.0, Bio- Rad Laboratories).
Total internal reflection fluorescence imaging
HEI- OC1 cells were cultured on glass- bottom dishes 
(MatTek) and preincubated as described for 2 hours 
in Krebs- Ringer bicarbonate buffer containing 2 mM 
glucose, 10 mM HEPES, pH 7.4, 120 mM NaCl, 5 mM 
NaHCO3, 5 mM KCl, 1.2 mM KH2PO4, 2.5 mM CaCl2, 
1.2 mM MgSO4 and 0.2% BSA at 33°C. The cells were 
stimulated without or with 10 nM insulin for 7 min. Subse-
quently, the cells were fixed using 4% paraformaldehyde 
and incubated with antibodies as indicated (1 hour per 
primary antibody and 1 hour per secondary antibody) in 
a buffer containing 1% BSA, 1% goat serum and 0.05% 
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Figure 2 High fat diet (HFD) feeding induces expansion of the endolymphatic fluid compartment in C57BL/6J mice when 
comparing the same ear before and after feeding. (A–C) Data are presented as: (A) means±SEM corresponding to all animals 
in the study shown for all ears (T), right ears (R) and left ears (L) (mean±SEM: before HFD (pre), 66.4±0.50 (T), 65.6±0.7 (R), 
67.2±0.6 (L) and after HFD (post), 72.7±1.1 (T), 73.7±1.7 (R), 71.6±1.5 (L), respectively; p=0.000073 (T), 0.015 (R), 0.021 (L), 
(B) as individual values before and after HFD and (C) as individual values for each ear with prevalues set to 1. (D) Example 
of images parallel to the modiolus of cochlea analyzed by MRI both before and after HFD feeding is shown. The gadolinium 
contrast moves into the perilymph (SV and ST), but not into the endolymph (SM), therefore the perilymph looks white and the 
endolymph looks black. Note the significant decrease in SV relative area after HFD feeding. The relative area of SM in the 
basal turn of the cochlea was estimated as described in ‘Methods’ section. The ratio of areas was subsequently converted 
to percentage as shown in A–C. SV, scala vestibule; ST, scala tympani; SM, scala media. (E) Time course in changes in body 
weight from baseline at 8 weeks of age and during 30 days on HFD (eight mice). MRI was performed at days indicated. Data 
are presented as means±SD. *P<0.05, **p<0.01,***p<0.001 vs day −1.
saponin. To visualize actin the cells were incubated with 
phalloidin (Invitrogen) for 1–2 hours.
For total internal reflection fluorescence (TIRF) 
imaging we used a commercial TIRF system based 
on a Nikon Ti- E eclipse microscope equipped with a 
100×Apo TIRF DIC oil immersion objective with a NA 
of 1.49 (Nikon Instruments), an iXon Ultra DU-897 
EMCCD camera (Andor Technology) and four main 
laser lines: 405 (Cube, Coherent), 488 (Melles- Griot), 
561 (Sapphire, Coherent) and 640 (Cube, Coherent) 
with corresponding filter sets.
Antibodies
The following primary antibodies were used for western 
blot analysis/TIRF microscopy as indicated: pACC Ser79 
#3661, ACC #3662, pPKBSer473 #9271, PKB #9272, pAMPK 
Thr172 #2535, anti- AMPK #2603 (all from Cell Signal-
ling), PDE1B and PDE4D antibodies were from Scottish 
Biomedical, the PDE3B antibody was made in house, Hsp 
90 (610418, BD Biosciences), GAPDH (Sigma- Aldrich, St 
Louis, Missouri, USA), fatty acid synthase (FAS) (sc20140) 
were from Santa Cruz. Antirabbit and antimouse secondary 
antibodies conjugated to HRP were from Thermo Fisher 
Scientific (Rockford, Illinois, USA) and GE Healthcare 
(Little Chalfont, UK), respectively.
Immunoprecipitation and in vitro assay of AMP-activated 
kinase activity
Lysates containing 5 μg of protein were incubated at 4°C 
for 1–2 hours on a shaking platform with 2 μg AMPKα1 
antibody generated in house by immunizing rabbits with 
a peptide encompassing residues 344–358 of rat AMPKα1 
(TSPPDSFLDDHHLTR) (Innovagen, Lund, Sweden), 
conjugated to 5 μL packed protein G- Sepharose (GE 
Healthcare Biosciences, Uppsala, Sweden). AMP- activated 
kinase (AMPK) assay was performed exactly as previously 
described using AMARA peptide (AMARAASAAALARRR) 
(GL Biocem, Shanghai) as substrate (for 20 min at 30°C).25 
Incorporation of 32P- phosphate was expressed as pmol ATP 
incorporated/mg protein/min (mU/mg).
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Measurement of Pde activity
HEI- OC1 cells were harvested in PDE buffer containing 
50 mM TES, pH 7.4, 250 mM sucrose, 1 mM EDTA, 1 mM 
DTT and Complete (Roche, protease inhibitors) (200 μL/
well) and subjected to sonication (2×10 pulses). Homoge-
nates were centrifuged for 5 min at 5000×g. PDE1 and PDE4 
activities were measured in the supernatants. PDE3 activity 
was measured in a membrane fraction. The 5000×g super-
natant was centrifuged at 100 000×g for 60 min at 4°C and 
membranes were suspended in PDE buffer (500 μL/plate). 
The following PDE inhibitors were used at final concen-
trations: 10 μM of the PDE3 inhibitor OPC3911 (Osaka, 
Japan), 10 μM of the PDE4 inhibitor RO-20 (Roche) 
and 50 μM of the PDE1 inhibitor 8MM- IBMX (Enzo Life 
Science, Farmingdale, New York, USA). The non- selective 
PDE inhibitor IBMX was used at 100 μM final concentra-
tion. Assays were performed at 30°C in a total volume of 
300 μL of buffer containing 50 mM TES pH 7.4, 250 mM 
sucrose, 1 mM EDTA, 0.1 mM EGTA and 8.3 mM MgCl2, 
0.5 μM cAMP, 0.5 μg ovalbumin and 1 μCi/mL 3H cAMP 
(55 000–65 000 cpm).26
Measurement of hormone-sensitive lipase activity
HEI- OC1 cells and mouse adipose tissue were homog-
enized in 0.25 M sucrose, 1 mM EDTA, 1 mM DTE and 
protease inhibitors (20 μg/mL leupeptin, 2 μg/mL anti-
pain, 1 μg/mL pepstatin), pH 7.0, using a glass- glass 
homogenizer. To remove fat from the adipose tissue 
homogenate, it was centrifuged at 110 000×g for 1 hour 
at 4°C and the fat- free infranatant was used for hormone- 
sensitive lipase (HSL) activity measurements. As a positive 
control in the HSL activity measurements, recombinant 
rat HSL was used. Measurement of HSL activity was 
performed using 1 (3)- oleoyl-2–0- oleylglycerol, a diacyl-
glycerol analogue, as substrate, as described in detail by 
Osterlund and Holm.27 To estimate the fraction of activity 
accounted for by HSL, samples were pre- incubated with 
either an activity- neutralizing hen antirat HSL serum 
(prepared in- house) or pre- immune serum for 15 min 
at 37°C prior to the assay. Total protein content of the 
samples was measured using the Bradford method and 
activity was expressed as mU/mg protein, where 1 U 
corresponds to the release of 1 μmol of fatty acids per 
min at 37°C.
statistical analysis
Results are expressed as mean±SEM. Differences between 
groups were tested for statistical significance using paired 
or non- paired Student’s t-test. P values <0.05 were consid-
ered to denote statistical significance.
ResulTs
Impact of insulin resistance on mouse inner ear
As shown in figure 1A–D, mice fed HFD showed signifi-
cantly larger EFCs compared with mice fed CD. HFD- 
induced hydrops developed in the right as well as in 
the left ears (figure 1C). The body weight of mice fed 
HFD was significantly higher after 14, 21 and 30 days, 
respectively, compared with the body weight of mice fed 
CD (figure 1E).
We also performed a longitudinal study of the effect 
of HFD on the size of the EFC in C57BL/6J mice, both 
before and after 30 days of HFD feeding. As shown in 
figure 2A,D, HFD significantly induced an expansion 
of the EFC. HFD- induced hydrops developed in the 
right as well as in the left ears (figure 2A). In figure 2B, 
prevalues and postvalues are shown for each ear and in 
figure 2C, the pretreatment value was set to 1 for each 
ear. After the initiation of HFD feeding, significant 
weight gain was obtained after 7, 14, 21 and 30 days 
(figure 2E).
Thus, in agreement with the known association 
between diabetes and inner ear dysfunction, mice with 
HFD- induced insulin resistance develop EH.
The organ of Corti was recently shown to express the 
insulin receptor.17 To investigate whether the cochlea 
could be a direct target for insulin signaling, we used 
HEI- OC1 auditory cells as a model for organ of Corti 
cells.
Insulin induces phosphorylation of PKB in HeI-OC1 cells
Insulin induced a dose- dependent and time- dependent 
phosphorylation of PKB at the activity- controlling site 
Ser473 (figure 3A,B) in the plasma membrane in HEI- 
OC1 auditory cells (figure 3C). Cells were co- stained with 
actin to confirm that image analysis was done close to the 
plasma membrane (figure 3C, upper panel).
Insulin- induced phosphorylation of PKB was blocked 
by wortmannin, a PI3- kinase inhibitor, isoproterenol, a 
β-adrenergic receptor agonist and by IBMX, a general 
PDE inhibitor (figure 3D–F). Rolipram (PDE4 inhibitor), 
8 MM IBMX (PDE1 inhibitor) or cilostamide (PDE3 
inhibitor) did not significantly antagonize the insulin- 
induced effect (data not shown), although the respective 
PDE subtype was expressed (figure 3G lower panel) and 
catalytically active (figure 3G upper panel) in HEI- OC1 
cells.
Insulin decreases and AICAR increases phosphorylation of 
acetyl-CoA carboxylase in HeI-OC1 cells
Insulin lowered the phosphorylation of acetyl- CoA 
carboxylase (ACC) at Ser79, an inhibitory phosphor-
ylation site (figure 4A). AICAR, an AMPK activator, in 
turn increased ACC Ser79 phosphorylation (figure 4B). 
AMPK activation was verified by increased Thr172 phos-
phorylation (figure 4C) and increased in vitro kinase 
activity (figure 4D). FAS, the enzyme complex catalyzing 
the synthesis of fatty acids (figure 4F) as well as HSL, 
the rate- limiting enzyme in lipolysis (figure 4E), were 
expressed in HEI- OC1 cells. Lipase activity, as measured 
using a diacylglycerol analogue as substrate, was inhib-
ited to approximately 50% by an HSL antiserum, whereas 
diacylglycerol lipase activity in an adipose tissue homoge-
nate as well as that of recombinant HSL were completely 
inhibited (figure 4E).
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Figure 3 Insulin (ins) induces phosphorylation of protein kinase B (PKB) in the plasma membrane of House Ear Institute- 
Organ of Corti 1 (HEI- OC1) auditory cells. (A) HEI- OC1 cells were stimulated with different concentrations of ins for 10 min 
(n=4–6) and (B) with 1 nM ins for 0–40 min (n=3–6). Phosphorylation of PKB was analyzed by western blot analysis using PKB 
Ser473 antibody. (C) Total internal reflection fluorescence (TIRF) imaging was performed on HEI- OC1 cells stimulated without 
or with 10 nM ins for 7 min prior to fixation and cells co- stained with PKB Ser473 antibody and actin antibody (upper panel) or 
with PKB Ser473 antibody (lower panel). A representative image from three experiments is shown. Scale bar=20 μm. (D) HEI- 
OC1 cells were stimulated without or with ins (1 and 10 nM) for 30 min without or with 100 μM wortmannin (wort) (added 30 min 
before ins) (n=3), (E) 10 nM ins with or without 30 nM isoproterenol (iso) (n=4) or (F) 1 nM ins with or without 100 μM IBMX (n=6). 
Phosphorylation of PKB was analysed by western blot analysis using PKB Ser473 antibody (samples are shown in duplicate for 
E and F). (G) Total cell lysates or membrane fractions (for measurement of phosphodiesterase (PDE)3 activity) were assayed for 
PDE1 (inhibited by 8 MM IBMX) (n=5), PDE4 (inhibited by rolipram) (n=5) and PDE3 (inhibited by cilostamide) (n=4) and also for 
PDE activity inhibited by IBMX (IBMX inhibitable (i) PDE) (n=5), as indicated. Western blot analysis using PDE4D, PDE1B and 
PDE3B antibodies are shown (lower panel). Blots are representative of three to six independent experiments. pPKB western 
blot analysis signals were normalized to untreated control samples not stimulated by ins (A, B, D, E) or to samples stimulated 
with ins only (F). Data are presented as means±SEM. *P<0.05, ***p<0.001 vs control (A, B, D, E), †p<0.05 vs ins only (D, E, F). 
Hsp90, heat shock protein 90.
dIsCussIOn
In this study, we investigated the presence and size of 
EH in HFD- fed C57BL/6J mice using MRI and gado-
linium,20 22 23 and insulin signaling in HEI- OC1 auditory 
cells. Importantly, the development of EH was used as a 
marker for inner ear dysfunction, but the mechanisms 
involved in hydrops development were not addressed. 
Our results indicate that HFD- fed C57BL/6J mice indeed 
develop inner ear EH and that insulin signaling takes 
place in HEI- OC1 cells.
C57BL/6J mice fed HFD is a robust and widely used 
model to study effects of insulin resistance, impaired 
glucose homeostasis and early type 2 diabetes.21 In a 
recent study from our laboratory, using the same batch 
of HFD and the same mouse strain, the onset of insulin 
resistance and lowering of insulin- induced phosphoryla-
tion of PKB was noted already after 2 days on HFD.28
Our present results, indicating dysfunction of the inner 
ear by HFD feeding using EH as a read- out, agree with 
several previous studies showing HFD- induced damage to 
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Figure 4 Insulin decreases and AICAR increases the phosphorylation of acetyl- CoA carboxylase (ACC) in House Ear Institute- 
Organ of Corti 1 (HEI- OC1) cells. (A) HEI- OC1 cells were stimulated without or with 1 nM insulin for 0–60 min (n=4) or (B–D) 
with 1 mM AICAR (n=3) for 60 min. The phosphorylation state of ACC and AMP- activated kinase (AMPK) were analyzed by 
western blot analysis using ACC Ser79 (A, B) and AMPK Thr172 (C) antibodies and the activity state of AMPK was measured 
against the peptide substrate AMARA in AMPK immunoprecipitates (n=3) (D). Blots are representative of three to four 
independent experiments (samples are shown in duplicate). pACC and pAMPK western blot analysis signals were normalized 
to control samples not stimulated by insulin or AICAR. For effect of insulin on ACC phosphorylation (A), the 20 min time point 
was used for quantification. (E) Hormone- sensitive lipase (HSL) activity was determined by immune- inhibition and compared 
with a control sample incubated with a preimmune serum as described in ‘Methods’ section (n=3). (F) HEI- OC1 cells were 
stimulated without or with 10 nM insulin for 0–60 min. The expression of FAS was analyzed by western blot analysis using FAS 
antibody, shown is a representative blot. Data are presented as means±SEM. *P<0.05, **p<0.01 vs control (con) (A–D). DAG, 
diacylglycerol; FAS, fatty acid synthase; GAPDH, glyceraldehyde-3- phosphate dehydrogenase; Hsp90, heat shock protein 90; 
ins, insulin.
the inner ear.10 29 30 To our knowledge, the development 
in vivo of EH using MR and gadolinium has not previ-
ously been reported on in the context of insulin resis-
tance and diabetes. Furthermore, it should be noted that 
in the present study EH developed already after 4 weeks 
of HFD feeding.
It should be noted that type 1 diabetes and type 2 
diabetes could impact on the auditory systems by common 
mechanisms related to hyperglycemia. However, insulin 
resistance or hyperinsulinemia, characteristic features of 
type 2 diabetes, may cause damage via separate mecha-
nisms.10 11 Thus, development of EH in our study could 
be related to systemic hyperglycemia and/or insulin resis-
tance/hyperinsulinemia. It has been shown that admin-
istration of insulin to guinea pigs leads to reduction in 
[K+] and increase in [Na+] in the endolymph, which, by 
increasing the osmotic pressure, could result in EH.13 14 
Furthermore, administration of insulin to guinea pigs 
has been shown to reduce cochlear microphonics and 
administration of insulin to sheep showed reductions in 
DPOAE indicating loss of outer hair cells’ function.15 16 
Interestingly, in a recent cross- sectional study insulin resis-
tance, impaired fasting glucose and beta- cell dysfunction 
were reported as independent risk factors for impaired 
hearing.12
Development of EH could also be related to altered 
levels of adipose tissue- derived factors such as increased 
flux of free fatty acids, increased release of proinflam-
matory cytokines and altered secretion of adipokines.31 
Interestingly, adiponectin, one of the major adipokines 
released from adipocytes, was suggested to be a 
mediator of obesity- associated, age- related hearing 
impairment.32
The finding that classical insulin signaling, involving 
the PI3- kinase/PKB node, takes place in HEI- OC1 cells 
agrees with a recent study showing the expression of the 
insulin receptor in supporting cells of the organ of Corti 
from mouse17 and also with the expression of insulin 
signaling components in the human saccule sensory 
epithelium.19 20 Regarding the PI3- kinase/PKB signaling 
node, several studies have demonstrated that a decrease 
in PI3- kinase/PKB signaling in the organ of Corti 
cells is associated with hearing loss.33 34 Also, following 
aminoglycoside treatment, PI3- kinase/PKB signaling 
has been shown to protect against gentamycin ototox-
icity in explants of the organ of Corti.35 These results 
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are compatible with a negative impact of organ of Corti 
insulin resistance on hearing.
The cross- talk between insulin and cAMP is highly rele-
vant, cAMP being a key component in the regulation 
of ion and fluid homeostasis in the inner ear.36 37 For 
example, as in the kidney, in the inner ear vasopressin 
acts on aquaporin 2 and fluid transport via increases in 
cAMP.36 The findings that IBMX, a general PDE inhib-
itor, could mimic the ability of isoproterenol to reduce 
the insulin signaling capacity indicates a role for PDEs 
in the cross- talk with insulin. The expression of cAMP- 
degrading and cGMP- degrading enzymes PDE1B, PDE3B 
and PDE4D in HEI- OC1 auditory cells is in agreement 
with previous results showing the expression of these and 
other PDE family members in the human saccule19 38 and 
with results showing the development of EH in response 
to PDE3 and PDE4 inhibitors.20 However, we could not 
demonstrate a connection between PDE1, PDE3 or PDE4 
and insulin signaling in HEI- OC1 cells such as that shown 
in adipocytes and hepatocytes, where insulin lowers 
cAMP by activating PDE3B.39
Our results indicate that enzymes involved in de 
novo lipogenesis and lipolysis, ACC, FAS and HSL, are 
expressed in HEI- OC1 cells, and that insulin lowers the 
phosphorylation of ACC. The latter is presumably asso-
ciated with increased synthesis of fatty acids and forma-
tion of triglycerides. We also show that phosphorylation 
of ACC increased when cells were incubated with AICAR, 
an activator of AMPK, a major regulator of cellular energy 
homeostasis. Altered expression/activity of AMPK in 
the organ of Corti has previously been shown to protect 
against as well as promote hearing loss following acoustic 
overstimulation.40 41 The role of ACC in AMPK- mediated 
effects on hearing remains to be clarified.
Interestingly, lipid droplets have been detected in 
Hensen cells in the auditory organ and it has been 
suggested that these droplets have an important role in 
inflammatory responses in the cochlea.42 In adipocytes, 
the main role for HSL is to catalyze the hydrolysis of stored 
triacylglycerols during periods of energy shortage.39 In 
addition to the generation of energy substrates, HSL 
could also provide the auditory cells with lipid signaling 
molecules, for example, long- chain acyl- CoA and diacyl-
glycerol (DAG) which has been described in other cell 
types, for example, in pancreatic beta- cells.43 In various 
non- adipocyte- producing or non- steroid- producing cells, 
including beta- cell lines and in rat and mouse islets, DAG 
lipase activity has been reported in the range of 2.2–9.2 
mU/mg protein and HSL immuno- inhibition was from 
22% to 77%43 in agreement with our results in HEI- OC1 
cells.
In conclusion, insulin might impact on the organ of 
Corti by mechanisms used in classical target cells for 
insulin action. Thus, defects in inner ear insulin action 
could contribute to the previously described associa-
tion between diabetes and inner ear dysfunction.1–5 It is 
possible that direct effects of insulin signaling on regu-
latory systems for fluid and ion homeostasis as well as 
energy metabolism act as a new regulatory mechanism 
for the organ of Corti in normal situations and in disease. 
Although in the present study mechanisms for the devel-
opment of EH have not been addressed, it is possible that 
defects in insulin action in the organ of Corti contrib-
utes to the development of EH since the vasopressin/
aquaporin 2 system as well as key ion transporters, Na,K- 
ATPase and the sodium transporter Enac, are known to 
be expressed in the organ of Corti.44–47 Interestingly, in 
kidney cells, insulin has been shown to regulate these 
transporters.48 49 On the other hand, EH could just be a 
marker for risk to develop inner ear/cochlear dysfunction 
independent of the causative etiology, perhaps making 
the organ of Corti cells more vulnerable to metabolic 
stressors, such as dysregulated glucose homeostasis and 
insulin resistance/hyperinsulinemia. Glucose is consid-
ered to be the primary energy source for the cochlea and 
interestingly, insulin- dependent glucose uptake in the 
organ of Corti was recently reported.17 Although there is 
no indication that cells from the stria vascularis express 
insulin receptors,17 we plan to investigate them in the 
near future because of their key role in the production 
of the endolymph. However, we anticipate problems in 
separating the contribution of cells from the cochlea and 
the stria vascularis since the composition of the endo-
lymph and the endocochlear potential depends both 
on the active electrogenic extrusion of K+ into the scala 
media by the stria vascularis and by the passive drainage 
of K+ from scala media, largely through the hair cells in 
the organ of Corti.50
study limitation and future research
We used MR and gadolinium contrast to demonstrate an 
expansion of the EFC as a marker for inner ear dysfunc-
tion in the context of HFD/insulin resistance. A limitation 
of this study, however, is that we have not directly inves-
tigated mice cochleae in regard to morphology (IHC), 
protein expression and, most important, we did not 
provide direct evidence that the cochlea in vivo is a target 
of insulin action or resistance. It will be important to link 
such mechanisms to (dys)regulation of inner ear fluid 
and energy homeostasis, and we plan to address these 
questions in upcoming studies. It will also be of impor-
tance to take into consideration the interaction between 
type 2 diabetes and age- induced hearing loss, since it has 
been shown in animal models that age- induced hearing 
loss is enhanced by diabetes.5 9
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